Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma

Cancer

Volumn 85, Issue 3, 1999, Pages 640-650

  Schagen, Sanne B ^a   Van Dam, Frits S A M ^a,b   Muller, Martin J ^a   Boogerd, Willem ^a,c   Lindeboom, Jaap ^d   Bruning, Peter F ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Department of Neurology ^*  (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adjuvant chemotherapy; Breast carcinoma; Cognitive deficits; Cyclophosphamide; Methotrexate, and 5 fluorouracil (CMF; Neurotoxicity

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DYSPNEA; FATIGUE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN; POSTOPERATIVE CARE; PRIORITY JOURNAL; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATTENTION; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; DEPRESSION; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SOCIOECONOMIC FACTORS;

EID: 0033082318     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G     Document Type: Article

References (52)

1. Forbes FF. The control of breast cancer: the role of tamoxifen. Semin Oncol 1997;24:5-19.
2. Bruning PF, Paridaens R. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer. A phase III study (EORTC 10901) of the EORTC Breast Cancer Cooperative Group. PDQ system of the NCI. Bethesda, MD: 1-13.
3. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992;339:1-15.
4. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992;339:71-85.
5. Olivotto JA, Bajdik CD, Math M, Plenderleith JH, Coppin CM, Gelmon KA, et al. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med 1994;330:805-10.
6. Harris J, Morrow M, Norton L. Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA .Cancer: principles & practice of oncology. Volume 2. 5th edition. Philadelphia: Lippincott-Raven Publishers, 1997:1541-616.
7. Bonadonna G, Brusamolino E, Valagussa P. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405-10.
8. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 1995;332:901-6.
9. Silberfarb PM, Philibert D, Levine PM. Psychosocial aspects of neoplastic disease. II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry 1980;137: 597-601.
10. Oxam TE, Silberfarb PM. Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 1980;137: 1263-5.
11. Parth P, Dunlap WP, Kennedy RS, Lane NE, Ordy JM. Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept Mot Skills 1989;68:1227-41.
12. Devlen J, Maguire P, Phillips P, Crowther D. Psychological problems associated with diagnosis and treatment of lymphomas. II. Prospective study. Br Med J 1987;295:955-7.
13. Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Hensley-Downey PJ. Neuropsychological impairment in adult bone marrow transplant candidates. Cancer 1992; 70:2288-97.
14. Meyers CA, Abbruzzese JL. Cognitive functioning in cancer patients: effect of previous treatment. Neurology 1992;42: 434-6.
15. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 1995;4:61-6.
16. Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during and after bone marrow transplantation. J Clin Oncol 1994;12:820-6.
17. Meyers CA, Byrne K, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995;12:231-5.
18. Cull A, Gregor A, Hopwood P, Macbeth F, Karnicka-Mlodkowska H, Thacher N, et al. Neurological and cognitive impairment on long-term survivors of small cell lung cancer. Eur J Cancer 1994;30a:1067-74.
19. Ahles TA, Tope DM, Frustenberg C, Hann D, Mills L. Psychological and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 1996;14:1457-62.
20. Oosterhout AGM, Ganzevles PGJ, Wilmink JT, de Geus BWJ, Vonderen RGMW, Twijnstra A. Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1996;5:1037-44.
21. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do patients mean when they complain of concentration and memory problems? Br J Cancer 1996;74:1674-9.
22. van Dam FSAM, Schagen SB, Muller MJ, Boogerd W, van de Wall E, Doorglever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-8.
23. Bouma A, Mulder J, Lindeboom J. Neuropsychologische diagnostiek. Handboek. Lisse: Swets & Zeitlinger, 1996.
24. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France, 1964.
25. Van den Burg W, Saan RJ, Deelman BG. 15-woordentest. Provisional Manual. Groningen: University Hospital, Department of Neuropsychology, 1985.
26. Alpherts WCJ, Aldenkamp AP. Fepsy. The iron fepsy. Instituut voor epilepsiebestrijding Heemstede, 1994.
27. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;12:242-8.
28. Hammes JGW. De Stroop kleur-woord test. Handleiding, tweede gewijzigde druk. Lisse: Swets & Zeitlinger, 1978.
29. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-6.
30. Brickenkamp R. Test d2. Aufmerksamkeitsbelastungstest. Handanweisung. Göttingen: Hochrefe, 1978.
31. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 1941;28:286-340.
32. Osterrieth PA. Le test de copie d'une figure complexe: contribution a l'etude de l'aperception et de la memoroire. Arch Psychol 1944;30:205-353.
33. Deelman BG, Liebrand WBG, Koning-Haanstra M, Burg van de W. S.A.N. Test, een afasietest voor mondeling en auditief taalgebruik. Lisse: Swets en Zeitlinger B.V., 1881.
34. Wechsler D. Wechsler Adult Intelligence Scale. New York: Psychological Corporation, 1955.
35. Wechsler D. Wechsler Memory Scale, revised. New York: Psychological Corporation, 1987.
36. Schmand B, Lindeboom J, van Harskamp F. De Nederlandse Leestest voor Volwassenen. Lisse: Swets & Zeitlinger 1992.
37. Huyser Y. De symptomatologie van depressieve stoornissen en angststoomissen. Amsterdam: Benecke Consultants, 1993.
38. Aaronson NK, Ahmedzi S, Bergman B, Bullinger M, Cull A. The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
39. Lezak MD. Neuropsychological assessment. 3rd edition. New York: Oxford University Press, 1995.
40. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994;30a:37-40.
41. Vercoulen JHMM, Bazelmans E, Swanink CMA, Galama JMD, Fennis JFM, van der Meer JWM, et al. Evaluating neuropsychological impairment in chronic fatigue syndrome. J Clin Exp Neuropsychol. 1998;20:144-56.
42. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20-6.
43. Sherwin BB. Estrogen effects on cognition in menopausal women. Neurology 1997;7:21-6.
44. Sunderland A, Harris JE, Gleave J. Memory failures in everyday life following severe head injury. J Clin Neuropsychol 1984;127-42.
45. Sunderland A, Watts K, Baddelely AD, Harris JE. Subjective memory assessment and test performance in eldery adults. J Gerontol 1986;41:376-84.
46. Wilson B, Cockburn J, Baddeley A, Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 1989;11:855-70.
47. Vermeulen J, Aldenkamp AP, Alpherts WCJ. Memory complaints in epilepsy: correlations with cognitive performance and neuroticism. Epilepsy Res 1993;15:157-70.
48. Ponds RWHM, Jolles J. Memory complaints in elderly people: the role of memory abilities, metamemory, depression and personality. Educ Gerontol 1996;22:341-57.
49. Boogerd W. Neurological complications of chemotherapy. In: Vinken and Bruyn. Handbook of clinical neurology: Intoxications of the nervous system. Part II. Elsevier Science, 1995: 527-46.
50. Kaplan RS, Wiernik PH. Neurotoxicity of antineoplastic drugs. Semin Oncol 1982;9:103-30.
51. Lynch HT, Droszcz CP, Albano WA, Lynch JF. Organic brain syndrome secondary to 5-fluorouracil toxicity. Dis Colon Rectum 1994;24:130-1.
52. Bleyer WA. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 1981; 1:89-98.